Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-14 · accession 0001104659-23-119162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-16 | 2023-11-14 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S - Sale+OE | $28.13 | -1,110 | 5,681 | -16% | -$31.2K |
| D | 2023-11-16 | 2023-11-14 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $9.24 | +2,000 | 6,791 | +42% | +$18.5K |
| D | 2023-11-16 | 2023-11-14 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-14 | S | D | 1,110 | $28.13 | 5,681 | D | — | — | (F2) Represents the number of shares of common stock sold to cover the exercise price of the employee stock options. |
| 2 | Common | Common Stock | 2023-11-14 | M | A | 2,000 | $9.24 | 6,791 | D | — | — | (F1) Includes an aggregate of 343 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-14 | M | D | 2,000 | $0.00 | 0 | D | $9.24 · — to 2024-01-21 | 2,000 Common Stock | (F3) The option vested in four equal annual installments beginning on January 21, 2015. |